MorningMed is a community of 814,300 medical professionals

We're a place where medical professionals share news and other news items to help their peers stay up to date

All articles tagged: Secondary malignant neoplasm of brain (C79.31)

HealthDay 20 June at 08.47 PM

FDA Approves Augtyro for NTRK-Positive Advanced Solid Tumors

The U.S. Food and Drug Administration has approved Augtyro (repotrectinib), a next-generation tyrosine kinase inhibitor (TKI), for the treatment of patients with neurotrophic tyrosine receptor kinase (NTRK)-positive locally advanced or metastatic solid tumors.Augtyro is approved for adult and pediatric patients (aged 12 years and olde

Evalytics 19 March at 06.09 AM

In two early trials, blood cancer treatment appears promising for deadly brain tumor

Recent trials have demonstrated promise in treating glioblastoma, an aggressive brain cancer with a bleak prognosis and no cure. Two small-scale trials showcased the potential of personalized immunotherapy, specifically CAR-T therapy, in patients with recurrent glioblastoma.

HealthDay 19 December at 04.18 PM

San Antonio Breast Cancer Symposium, Dec. 5 to 9

The annual San Antonio Breast Cancer Symposium was held from Dec. 5 to 9 in San Antonio, with attendees including medical oncologists, radiation oncologists, researchers, and other health care professionals. The conference highlighted recent advances in the risk, diagnosis, treatment, and prevention of breast cancer, and presentations focused on emerging tr